Literature DB >> 22374983

Densely granulated murine NK cells eradicate large solid tumors.

Rebecca B Liu1, Boris Engels, Ainhoa Arina, Karin Schreiber, Elizabeth Hyjek, Andrea Schietinger, David C Binder, Eric Butz, Thomas Krausz, Donald A Rowley, Bana Jabri, Hans Schreiber.   

Abstract

Natural killer (NK) cells inhibit early stages of tumor formation, recurrence, and metastasis. Here, we show that NK cells can also eradicate large solid tumors. Eradication depended on the massive infiltration of proliferating NK cells due to interleukin 15 (IL-15) released and presented by the cancer cells in the tumor microenvironment. Infiltrating NK cells had the striking morphologic feature of being densely loaded with periodic acid-Schiff-positive, diastase-resistant granules, resembling uterine NK cells. Perforin-mediated killing by these densely granulated NK cells was essential for tumor eradication. Expression of the IL-15 receptor α on cancer cells was needed to efficiently induce granulated NK cells, and expression on host stromal cells was essential to prevent tumor relapse after near complete destruction. These results indicate that IL-15 released at the cancer site induces highly activated NK cells that lead to eradication of large solid tumors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22374983      PMCID: PMC3680344          DOI: 10.1158/0008-5472.CAN-11-3208

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

1.  Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.

Authors:  T A Fehniger; M H Shah; M J Turner; J B VanDeusen; S P Whitman; M A Cooper; K Suzuki; M Wechser; F Goodsaid; M A Caligiuri
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

2.  Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activity.

Authors:  Ryan A Wilcox; Koji Tamada; Scott E Strome; Lieping Chen
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

3.  "Thanatosomes": a unifying morphogenetic concept for tumor hyaline globules related to apoptosis.

Authors:  J C Papadimitriou; C B Drachenberg; D S Brenner; C Newkirk; B F Trump; S G Silverberg
Journal:  Hum Pathol       Date:  2000-12       Impact factor: 3.466

4.  Transduction of murine colon carcinoma cells with interleukin-15 gene induces antitumor effects in immunocompetent and immunocompromised hosts.

Authors:  K Tasaki; Y Yoshida; M Miyauchi; T Maeda; K Takenaga; T Kouzu; T Asano; T Ochiai; S Sakiyamna; M Tagawa
Journal:  Cancer Gene Ther       Date:  2000-02       Impact factor: 5.987

5.  NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer.

Authors:  K Suzuki; H Nakazato; H Matsui; M Hasumi; Y Shibata; K Ito; Y Fukabori; K Kurokawa; H Yamanaka
Journal:  J Leukoc Biol       Date:  2001-04       Impact factor: 4.962

6.  Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response.

Authors:  Toshiki Yajima; Hitoshi Nishimura; Worawidh Wajjwalku; Mamoru Harada; Hiroyuki Kuwano; Yasunobu Yoshikai
Journal:  Int J Cancer       Date:  2002-06-01       Impact factor: 7.396

7.  Gene transfer of a secretable form of IL-15 in murine adenocarcinoma cells: effects on tumorigenicity, metastatic potential and immune response.

Authors:  R Meazza; P L Lollini; P Nanni; C De Giovanni; A Gaggero; A Comes; M Cilli; E Di Carlo; S Ferrini; P Musiani
Journal:  Int J Cancer       Date:  2000-08-15       Impact factor: 7.396

8.  Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression.

Authors:  Maria R Parkhurst; John P Riley; Mark E Dudley; Steven A Rosenberg
Journal:  Clin Cancer Res       Date:  2011-08-15       Impact factor: 12.531

9.  The uterine NK cell population requires IL-15 but these cells are not required for pregnancy nor the resolution of a Listeria monocytogenes infection.

Authors:  Ellen M Barber; Jeffrey W Pollard
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

10.  Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice.

Authors:  Rima Koka; Patrick R Burkett; Marcia Chien; Sophia Chai; Faye Chan; James P Lodolce; David L Boone; Averil Ma
Journal:  J Exp Med       Date:  2003-04-14       Impact factor: 14.307

View more
  30 in total

Review 1.  T Cells and Regulated Cell Death: Kill or Be Killed.

Authors:  Johan Spetz; Adam G Presser; Kristopher A Sarosiek
Journal:  Int Rev Cell Mol Biol       Date:  2018-08-29       Impact factor: 6.813

2.  Interleukin-17D mediates tumor rejection through recruitment of natural killer cells.

Authors:  Timothy O'Sullivan; Robert Saddawi-Konefka; Emilie Gross; Miller Tran; Stephen P Mayfield; Hiroaki Ikeda; Jack D Bui
Journal:  Cell Rep       Date:  2014-05-01       Impact factor: 9.423

3.  An Overview of Advances in Cell-Based Cancer Immunotherapies Based on the Multiple Immune-Cancer Cell Interactions.

Authors:  Jialing Zhang; Stephan S Späth; Sherman M Weissman; Samuel G Katz
Journal:  Methods Mol Biol       Date:  2020

4.  Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for Glioma.

Authors:  Bingtao Tang; Zong Sheng Guo; David L Bartlett; David Z Yan; Claire P Schane; Diana L Thomas; Jia Liu; Grant McFadden; Joanna L Shisler; Edward J Roy
Journal:  Clin Cancer Res       Date:  2020-02-04       Impact factor: 12.531

Review 5.  Immune checkpoint blockade: a common denominator approach to cancer therapy.

Authors:  Suzanne L Topalian; Charles G Drake; Drew M Pardoll
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

6.  IFNα signaling through PKC-θ is essential for antitumor NK cell function.

Authors:  Natalia R Comet; Juan Ignacio Aguiló; Moeez G Rathoré; Elena Catalán; Johan Garaude; Gilles Uzé; Javier Naval; Julián Pardo; Martín Villalba; Alberto Anel
Journal:  Oncoimmunology       Date:  2014-11-14       Impact factor: 8.110

Review 7.  Balancing the innate immune system in tumor development.

Authors:  Catharina Hagerling; Amy-Jo Casbon; Zena Werb
Journal:  Trends Cell Biol       Date:  2014-11-28       Impact factor: 20.808

Review 8.  Innate and adaptive immune cells in the tumor microenvironment.

Authors:  Thomas F Gajewski; Hans Schreiber; Yang-Xin Fu
Journal:  Nat Immunol       Date:  2013-10       Impact factor: 25.606

9.  CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of glioma.

Authors:  Katherine A Murphy; Jami R Erickson; Charles S Johnson; Charles E Seiler; Jessica Bedi; Peisheng Hu; G Elizabeth Pluhar; Alan L Epstein; John R Ohlfest
Journal:  J Immunol       Date:  2013-11-29       Impact factor: 5.422

10.  Design and characterization of a protein superagonist of IL-15 fused with IL-15Rα and a high-affinity T cell receptor.

Authors:  Jennifer D Stone; Adam S Chervin; Hans Schreiber; David M Kranz
Journal:  Biotechnol Prog       Date:  2012-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.